Best of the Decade

We asked the four industrial divisions of Germany Trade & Invest to name their most significant or interesting investment case studies over the past 10 years.

August 2019

Energy ­Division

The German-Swiss software start-up ­enersis suisse AG from Bern opened a new location in Kleinmachnow, near Berlin, in 2015 – enersis europe GmbH. The company first made contact with Germany Trade & Invest in 2013, who advised them on the move. The Brandenburg Economic Development Corporation (WFBB) also provided support on site over the following years.

The company specializes in visual energy analytics and has positioned itself to make a substantial contribution to a successful digital energy transition by targeting utilities, DSOs, and municipalities. Its energy-specific software platform GRIDS applies a state-of-the-art proprietary data model as well analytics, machine learning, and visualization technologies and is compatible with major Internet of Things platforms in the field. Enersis plans to invest up to EUR 10 million by 2020/21 and hire 50-60 employees in sales, operations and development in Kleinmachnow.

© enersis swiss AG

Mechanical & Electronic Technologies Division

In 2018 one of the world’s leading battery cell manufacturers, the Chinese company Contemporary Amperex Technology Ltd. (CATL), decided to construct its first factory outside China at the Erfurter Kreuz industrial estate in Thuringia, Germany. The planned EUR 240 million investment, which will provide employment for 1,000 people, could ultimately turn out to be even bigger: the company recently announced that the original plan for 14 gigawatt hours (GWh) of capacity at the factory could be extended to 100 GWh by 2025.

GTAI industry expert Markus Hempel initiated the contact with CATL while working as the director of GTAI’s Shanghai office in China. GTAI offered the company several location options in Germany, providing extensive information on critical factors affecting the location choice. CATL compared these with offers from other European countries and opted for a base in eastern Germany. The Economic Development Agency of Thuringia (LEG Thueringen) supported the investment on site.

Ultimately, Germany was chosen for a number of reasons: the availability of qualified workers, the legally secure investment framework, the well-developed infrastructure and proximity to customers and, finally, the country’s political and economic policy, which supports more energy-efficient cell production.

© Bloomberg/Kontributor

Chemicals & Healthcare ­Division

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company and the largest generic drug manufacturer in the world.

In 2015 GTAI was contacted by a U.S. consulting company hired to identify an ideal production site for biopharmaceuticals. Working closely with local economic development agencies, GTAI supplied a vast amount of data for suitable sites across Germany. The decision in favor of a location in Germany – Ulm, Baden-Württemberg – was finally made about a year later.

The EUR 500 million production facility is currently under construction and will employ 300 new staff. On a recent visit, Kåre Schultz, president and CEO of Teva Pharmaceuticals, said: “One of our strategic goals is to become a global leader in biopharmaceuticals. Teva’s German location has an important strategic role to play in the future.”

© Uriel Sinai/Freier Fotograf

Consumer ­Industries Division

Tadim, the leading Turkish packaged nuts and dried fruits brand made its first contact with Germany Trade & Invest in 2013. They decided to set up a production facility in Emsdetten, North-Rhine Westphalia, one year later.

Since then the family-run firm (which is based in Gebze) has invested around EUR 7 million in the plant, which exports to Europe, the U.S., and Canada. In just two years, annual sales have reached EUR 12 million.

In 2017 Tadim announced it was investing an additional EUR 12 million to build a bigger production hall and office complex to boost output and increase its presence on European shelves. It takes unprocessed goods bought directly from the producer, processes them in a production line featuring state-of-the-art machinery without human contact, then packs and delivers them to the consumer at their freshest.

© agrobacter

More information